RCC arises in a unique context of renal tubular cell biology where the constitutive loss of VHL function drives HIF activation, which in turn upregulates key effectors such as CA9, monocarboxylate transporters (MCTs), and lipid metabolic enzymes. The gene discussed is CA9; the disease is renal cell carcinoma.